WHO Drug Information Vol. 25, No. 2, 2011

Proposed INN: List 105 WHO Drug Information Vol. 25, No. 2, 2011C 19 H 17 FN 8 O 2 625115-52-8NFNNNNH 2HN OCH 3NH 2ONnivocasanumnivocasannivocasannivocasán(5R)-N-[(2S,3S)-2-(fluoromethyl)-2-hydroxy-5-oxooxolan-3-yl]-3-(isoquinolin-1-yl)-5-(propan-2-yl)-4,5-dihydro-1,2-oxazole-5-carboxamidecaspase inhibitor(5R)-N-[(2S,3S)-2-(fluorométhyl)-2-hydroxy-5-oxooxolan-3-yl]-3-(isoquinoléin-1-yl)-5-(propan-2-yl)-4,5-dihydro-1,2-oxazole-5-carboxamideinhibiteur de la caspase(5R)-N-[(2S,3S)-2-(fluorometil)-2-hidroxi-5-oxooxolan-3-il]-3-(isoquinolin-1-il)-5-(propan-2-il)-4,5-dihidro-1,2-oxazol-5-carboxamidainhibidor de la caspasaC 21 H 22 FN 3 O 5 908253-63-4ONO ONHN O CH3H OHH 3 CFoclacitinibumoclacitiniboclacitiniboclacitinibN-methyl{trans-4-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclohexyl}methanesulfonamideantineoplastic (veterinary drug)N-méthyl[trans-4-(méthyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclohexyl]méthanesulfonamideantinéoplasique (produit vétérinaire)N-metil{trans-4-[metil(7H-pirrolo[2,3-d]pirimidin-4-il)amino]ciclohexil}metanosulfonamidaantineoplásico (medicamento veterinario)C 15 H 23 N 5 O 2 S 1208319-26-9O OH 3 C SNHCH 3NHNNN184